Effects of Hypoglossal Nerve Stimulation on Cognition and Language in Down Syndrome and Obstructive Sleep Apnea
Sponsor: Inspire Medical Systems, Inc.
A PHASE3 clinical study on Down Syndrome and Obstructive Sleep Apnea, this trial is ongoing. The trial is conducted by Inspire Medical Systems, Inc. and has accumulated 12 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Oct 2025 — Present [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Jan 2025 — Oct 2025 [monthly]
Recruiting PHASE3
-
Oct 2024 — Jan 2025 [monthly]
Recruiting PHASE3
-
Sep 2024 — Oct 2024 [monthly]
Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE3
▶ Show 7 earlier versions
-
May 2024 — Jul 2024 [monthly]
Recruiting PHASE3
-
Apr 2024 — May 2024 [monthly]
Recruiting PHASE3
Phase: PHASE2 → PHASE3
-
May 2023 — Apr 2024 [monthly]
Recruiting PHASE2
-
Sep 2022 — May 2023 [monthly]
Recruiting PHASE2
-
May 2022 — Sep 2022 [monthly]
Recruiting PHASE2
-
Sep 2021 — May 2022 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Apr 2021 — Sep 2021 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Inspire Medical Systems, Inc.
- National Institute on Deafness and Other Communication Disorders (NIDCD)
- National Institutes of Health (NIH)
For direct contact, visit the study record on ClinicalTrials.gov .